Beta Bionics, Inc.'s market cap is currently $976.34M. The company's EPS TTM is $-0.39; its P/E ratio is ―; Beta Bionics, Inc. is scheduled to report earnings on July 29, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
